IPP Bureau
SecureKloud to list subsidiary Healthcare Triangle on Nasdaq
By IPP Bureau - October 13, 2021
The company plans to raise US $ 15 million
Dr Reddy’s launch anti-cancer drug in China
By IPP Bureau - October 13, 2021
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
Lonza to expand development services for mammalian products in Singapore
By IPP Bureau - October 13, 2021
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
American Diabetes Association acknowledges Breath Well-being diabetes reversal programme
By IPP Bureau - October 13, 2021
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
By IPP Bureau - October 12, 2021
HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs
Skanray to raise Rs 400 crore to fund its inorganic growth
By IPP Bureau - October 12, 2021
Since its inception, the company has either acquired or taken a majority stake in five companies
Tarsons earmarks funds from IPO to double capacity at its Panchla facility
By IPP Bureau - October 12, 2021
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Algorithm to calculate number of years one lives with good health
By IPP Bureau - October 12, 2021
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Medtronic’s robotic-assisted surgery system receives European CE mark
By IPP Bureau - October 12, 2021
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
LSNE expands lyophilization capacity at Madison, USA
By IPP Bureau - October 12, 2021
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
Everest Organics develops API for molnupiravir
By IPP Bureau - October 12, 2021
The drug is being developed at lab scale for the first-line of treatment of Covid-19
.jpg "Covaxin for kids gets nod, final approval awaited")
Covaxin for kids gets nod, final approval awaited
By IPP Bureau - October 12, 2021
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Intas launches the world's first SB-100mg Itraconazole
By IPP Bureau - October 12, 2021
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
Boehringer Ingelheim launches University of Medicine Excellence
By IPP Bureau - October 12, 2021
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
Glenmark launches Tavulus for COPD treatment in Spain
By IPP Bureau - October 11, 2021
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
